NCT04654065

Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers

An Open-label, Single-dose Clinical Study to Evaluate Oral Mucosa Absorption of IN-C004 in Healthy Volunteers

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 6 (actual)
• Sponsor: HK inno.N Corporation · Industry
• Sex: All
• Age: 19 Years – 55 Years
• Healthy volunteers: Accepted

Summary

To evaluate whether IN-C004 absorbs oral mucosa in healthy volunteers.

Detailed description

An Open-label, Single-dose Clinical Study

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	IN-C004	One time dose of IN-C004 taken orally.

Timeline

• Start date: 2021-01-04
• Primary completion: 2021-01-05
• Completion: 2021-01-05
• First posted: 2020-12-04
• Last updated: 2021-01-29

Locations

1 site across 1 country: South Korea